Author Archives: John E. Fitzgibbon Jr.

“It ain’t over till it’s over.” That’s one of baseball legend Yogi Berra’s most famous lines. And that pretty well sums up the IPO market for August 2018. Historical data show the IPO traffic generally dries up in mid-August. This year, though, was different. Every week you would think that the new-issue calendar was done […]

This summer’s IPO market is turning out to be much like the B-grade horror movies of yesteryear. Every time you think the monster has been killed, surprise! It crawls back out of the shadows. Bankers found two SPACs, or “blank check” companies, to go public this week and they mixed in a reshuffled carryover from […]

The last rose of summer appears on this week’s IPO Calendar and then Wall Street is off to vacation land until after Labor Day. The $28 million deal, set for pricing on Monday night, is slated for Tuesday’s trading. The IPO is Aridis Pharmaceuticals (ARDS proposed), based in San Jose, California. It is a late-stage […]

The magic show of the summer’s IPO market closes this week. The calendar has five deals – and after that, it is a blank slate until after the Labor Day holiday. There’s no need to worry, though. This is a normal seasonal event. Looking back over the last 10 summers, starting with 2008 and running […]

July’s 2018 IPO market went out with a bang on Friday. Bankers priced 11 deals in the month’s final week and raised July’s total traffic to 20 IPOs. That was 53.8 percent above the median average of 13 IPOs for the month of July from 2001 through 2017. That was interesting because the month’s first […]